These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 10802863)
21. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-gamma correlate with the protection. Shi T; Liu WZ; Gao F; Shi GY; Xiao SD Helicobacter; 2005 Feb; 10(1):71-9. PubMed ID: 15691317 [TBL] [Abstract][Full Text] [Related]
22. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB. Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576 [TBL] [Abstract][Full Text] [Related]
23. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori. Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841 [TBL] [Abstract][Full Text] [Related]
24. A vaccine against Helicobacter pylori: towards understanding the mechanism of protection. Aebischer T; Walduck A; Schroeder J; Wehrens A; Chijioke O; Schreiber S; Meyer TF Int J Med Microbiol; 2008 Jan; 298(1-2):161-8. PubMed ID: 17702653 [TBL] [Abstract][Full Text] [Related]
25. Inflammation, Immunity, and Vaccine Development for the Gastric Pathogen Helicobacter pylori. Ikuse T; Blanchard TG; Czinn SJ Curr Top Microbiol Immunol; 2019; 421():1-19. PubMed ID: 31123883 [TBL] [Abstract][Full Text] [Related]
26. Perivascular Lymphocyte Clusters Induced by Gastric Subserous Layer Vaccination Mediate Optimal Immunity against Helicobacter through Facilitating Immune Cell Infiltration and Local Antibody Response. Hu C; Liu W; Xu N; Huang A; Zeng Z; Luo S; Zhang Z; Fan M; Ye F; Xi T; Xing Y J Immunol Res; 2020; 2020():1480281. PubMed ID: 32411786 [TBL] [Abstract][Full Text] [Related]
27. Preventive and therapeutic vaccines against Helicobacter pylori: current status and future challenges. Ernst PB; Pappo J Curr Pharm Des; 2000 Oct; 6(15):1557-73. PubMed ID: 10974152 [TBL] [Abstract][Full Text] [Related]
28. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens. Keenan JI; Rijpkema SG; Durrani Z; Roake JA FEMS Immunol Med Microbiol; 2003 May; 36(3):199-205. PubMed ID: 12738392 [TBL] [Abstract][Full Text] [Related]
29. [Current progress in the development of prophylactic and therapeutic vaccination against H. pylori infection]. Nishizono A Nihon Rinsho; 2002 Feb; 60 Suppl 2():745-50. PubMed ID: 11979882 [No Abstract] [Full Text] [Related]
30. The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases. Gómez-Duarte OG; Bumann D; Meyer TF Vaccine; 1999 Mar; 17(13-14):1667-73. PubMed ID: 10194821 [TBL] [Abstract][Full Text] [Related]
31. Inflammation, immunity, and vaccines for Helicobacter infection. Permin H; Andersen LP Helicobacter; 2005; 10 Suppl 1():21-5. PubMed ID: 16178967 [TBL] [Abstract][Full Text] [Related]
32. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model. Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531 [TBL] [Abstract][Full Text] [Related]
33. Systemic immunization with unadjuvanted whole Helicobacter pylori protects mice against heterologous challenge. Harbour SN; Every AL; Edwards S; Sutton P Helicobacter; 2008 Dec; 13(6):494-9. PubMed ID: 19166414 [TBL] [Abstract][Full Text] [Related]
35. Prospects for a mucosally-administered vaccine against Helicobacter pylori. Svennerholm AM Vaccine; 2003 Jan; 21(5-6):347-53. PubMed ID: 12531631 [No Abstract] [Full Text] [Related]
36. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia. Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972 [TBL] [Abstract][Full Text] [Related]
37. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883 [TBL] [Abstract][Full Text] [Related]
38. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. Lee CK; Weltzin R; Thomas WD; Kleanthous H; Ermak TH; Soman G; Hill JE; Ackerman SK; Monath TP J Infect Dis; 1995 Jul; 172(1):161-72. PubMed ID: 7797906 [TBL] [Abstract][Full Text] [Related]
39. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes. Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255 [TBL] [Abstract][Full Text] [Related]